The role of cardiac sympathetic denervation for ventricular arrhythmias: an updated systematic review and meta-analysis
Authors:
- 29 January 2025
- journal article
- research article
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 68 (2) , 415-425
Abstract
Introduction The role of the sympathetic nervous system in the initiation and continuation of ventricular tachyarrhythmias (VTA) is well established. However, whether CSD reduces implantable cardioverter-defibrillator (ICD) shocks and recurrent VTA is still uncertain. Methods A comprehensive literature search was performed at Medline and Embase until March 2023. The primary outcome was the rate of ICD shocks and VTA per patient-year in our pooled analysis of all included articles. Analyses were conducted using Comprehensive Meta-Analysis software. Results Initial search yielded 1324 scientific studies with a total of 15 studies fitting our inclusion criteria. ICD shocks at 1 year post-CSD revealed an event rate of 69.8% (95% CI, 56.4–80.4% with 50% heterogeneity) (I2 statistic). ICD shocks at 6 months had an event rate of 59.1% (95% CI, 46.9–70.4%; 47 I2). Analysis of our pooled studies showed that 64.3% of individuals achieved freedom from VTA at 1 year post-CSD (95% CI, 42.3–81.5%; 26% I2), while 62.3% were free from recurrent VTA 6 months post-CSD (95% CI, 51.2–72.2%; 40% I2). Time to mortality directly caused by recurrent VTA post-CSD was subdivided into short-term (0–30 days), intermediate-term (31–364 days), and long-term (≥ 365). Mortality for the short-term tertile was 8.9% (95% CI, 5.0–15.4%; 0% I2), medium-term was 5.3% (95% CI, 2.4–11.3%; 0% I2), and long-term 5.2% (95% CI, 2.4–10.9%; 0% I2). Conclusion CSD seems to be promising as an acceptable treatment strategy for recurrent VTA refractory to traditional pharmacological or ablation therapy. Graphical AbstractKeywords
This publication has 37 references indexed in Scilit:
- Ventricular Tachycardia Burden and Mortality: Association or Causality?Canadian Journal of Cardiology, 2022
- Limited Left Thoracoscopic Sympathectomy Effectively Silences Refractory Electrical StormThe Annals of Thoracic Surgery, 2022
- Cardiac sympathetic denervation in patients with nonischemic cardiomyopathy and refractory ventricular arrhythmias: a single-center experienceClinical Research in Cardiology, 2020
- Cardiac sympathetic denervation for refractory ventricular arrhythmias in patients with structural heart disease: A systematic reviewHeart Rhythm, 2019
- Cardiac sympathectomy for the management of ventricular arrhythmias refractory to catheter ablationHeart Rhythm, 2018
- Left sympathetic cardiac denervation in managing electrical storm: acute outcome and long term follow upJournal of Interventional Cardiac Electrophysiology, 2016
- Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: Intermediate and long-term follow-upHeart Rhythm, 2014
- Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgeryHeart Rhythm, 2009
- The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivityAmerican Heart Journal, 1985
- Recurrent ventricular tachycardiaThe American Journal of Medicine, 1961